Ken J. Bulpitt

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

Michael E. Weinblatt, Joel M. Kremer, Arthur D. Bankhurst et al. · New England Journal of Medicine · 1999 · 2.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.

Larry W. Moreland, S. Cohen, Scott W. Baumgartner et al. · PubMed · 2001 · 201 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Studies of sequence heterogeneity of mitochondrial DNA from rat and mouse tissues: Evidence for an increased frequency of deletions/additions with aging

Lajos Pikó, Andrina J. Hougham, Ken J. Bulpitt · Mechanisms of Ageing and Development · 1988 · 194 citations

Medicine, Genetics, Molecular Genetics +13

CAMPATH-1H IN RHEUMATOID ARTHRITIS—AN INTRAVENOUS DOSE-RANGING STUDY

John D. Isaacs, Vasant K. Manna, N T Rapson et al. · Lara D. Veeken · 1996 · 110 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus

Bevra H. Hahn, Ram Raj Singh, Weng Kee Wong et al. · Arthritis & Rheumatism · 2001 · 109 citations

Life Sciences, Immunology, Molecular Biology +17